Phase 1 trial HMR code: 22-017

Phase 1

• Conditions: Healthy volunteers; Not Applicable

• Registration Number: ISRCTN51803225
• Lead Sponsor: eurocrine Biosciences (United States)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-08-03
• Last Update Posted: 21 August 2023
• Study Completion: 2025-02-15

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 134

Inclusion Criteria

Healthy human volunteers

Exclusion Criteria

The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Secondary Outcome Measures

Name	Time	Method
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.